QNTM

HD

Consumer Discretionarylarge cap
QNTM SCORE
38/100
LOW CONVICTION
top 65% of the universe

As of 2026-09-10, HD scores 38out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. HD trades at $305.69, 18% above the band ceiling.

HD scores 38 out of 100 on QNTM's five-factor model — a low-conviction reading — at 38 the factor profile is among the weaker names in the universe. Its strongest factor is value at 69 (strong), where it screens cheap on the model's valuation inputs, followed by quality at 64. The weakest is momentum at 27, where price trend is the soft spot. Among Consumer Discretionary stocks it sits in the lower 35% of Consumer Discretionary names by composite.

On valuation, HD is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 52. Same-sector names the model rates nearby include ANF, BBY, HRB.

This is a descriptive factor read on HD, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where HD sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

Momentum27
Quality64
Value69
Volume41
Sentiment61

VALUATION RANGE

QNTM’s descriptive fair-value band for HD runs $195.06–$258.21. Current price $305.69 sits 18% above the band ceiling. This is valuation context, not a price target.

See HD update live, and set an alert when its conviction changes

QNTM rescores HD and ~1,400 other names every session. Track it, get notified the moment it crosses a conviction tier, and see the full signal history.

Start free →

OTHER CONSUMER DISCRETIONARY NAMES

ANF49BBY47HRB46EXPE46FTDR44DUOL44SIG43LAUR43

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.